Evaluating the effects of Growth Differentiating Factor 15 (GDF15) in the development of non-alcoholic steatohepatitis (NASH).

In Canada, over 30% of adults and 10% of children are affected with non-alcoholic fatty liver disease (NAFLD), a chronic condition often related to obesity. NAFLD refers to a range of conditions related to excess fat in the liver, unrelated to alcohol intake. NAFLD is a precursor to liver cirrhosis, end stage liver disease and […]

Read More